Health
Patrys Limited Announces Publication of PAT-DX1 Preclinical Data in JCI – GuruFocus.com
GuruFocus Article or News written by Business Wire and the topic is about:
Patrys+Limited (ASX:PAB, Financial), a therapeutic antibody development company, has announced the publication of preclinical data for its therapeutic antibody candidate PAT-DX1 in The Journal of Clinical InvestigationInsight. Patrys is developing PAT-DX1…
Continue Reading